Compare GSK & BN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSK | BN |
|---|---|---|
| Founded | 1715 | 1997 |
| Country | United Kingdom | Canada |
| Employees | 66841 | 250000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 99.3B |
| IPO Year | N/A | N/A |
| Metric | GSK | BN |
|---|---|---|
| Price | $52.18 | $42.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | N/A | ★ $49.87 |
| AVG Volume (30 Days) | 3.9M | ★ 4.0M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.40% | 0.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.99 | N/A |
| Revenue Next Year | $4.19 | $16.74 |
| P/E Ratio | ★ $32.75 | $93.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.45 | $37.93 |
| 52 Week High | $61.70 | $74.20 |
| Indicator | GSK | BN |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 36.33 |
| Support Level | $51.55 | $37.93 |
| Resistance Level | $53.45 | $47.40 |
| Average True Range (ATR) | 0.91 | 1.03 |
| MACD | 0.11 | -0.28 |
| Stochastic Oscillator | 58.87 | 3.51 |
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals, operating through seven segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity (which generates the highest revenue), Real Estate, and Corporate Activities. The company invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders, with the majority of its revenue coming from Asset Management. It has a presence across the United Kingdom, the United States (which contributes the highest revenue), Australia, Canada, Brazil, India, Colombia, Germany, other parts of Europe, other parts of Asia, and additional countries.